Skip to main content

Day: September 22, 2020

GDS Announces Accepted Offer to Acquire Major New Data Center in Beijing

SHANGHAI, China, Sept. 22, 2020 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS), a leading developer and operator of high-performance data centers in China, today announced that it has extended a legally-binding offer to acquire 100% of the equity interests in target companies which own a major data center in the Shunyi district of Beijing (“BJ14”) (the “Acquisition”). The target companies are owned by a private equity fund controlled by CITIC Private Equity Funds Management Co., Limited (“CPE”), a leading alternative asset manager in China, and its affiliated parties. The offer has been accepted, with exclusivity terms agreed by both parties. The total enterprise value of the Acquisition is approximately RMB3.8 billion, with a further RMB500 million contingent on the acquisition by the...

Continue reading

LGI Homes Announces New Community Near Austin

ELGIN, Texas, Sept. 22, 2020 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) today announced the opening of its newest community in the Austin market, Homestead Estates, offering an astounding line up of superior-quality homes with home prices starting in the $210s.Ideally located in Elgin, Texas, Homestead Estates is situated less than five minutes from Highway 290, allowing residents to get anywhere quickly. This premier location places homeowners in great proximity to downtown Austin, several local attractions, great shopping, dining and a host of major employers. Inside the community, LGI Homes is constructing a brand-new park with a children’s playground and a covered picnic pavilion. For those residents who live a more active lifestyle, there will also be a sand volleyball court and a community soccer field. Additionally,...

Continue reading

Microbix Presenting COVID-19 Product Results to Industry

MISSISSAUGA, Ontario, Sept. 22, 2020 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), an award-winning life sciences innovator and exporter, announces it is has been invited to present about the performance of its COVID-19 in-vitro diagnostics (IVD) quality assessment products at “ECCVID,” a virtual conference on Coronavirus disease organized by the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), taking place September 23-25, 2020.The abstract presentation is titled “Novel SARS-CoV-2 Full-Genome Material For Use In A Swab-based Formulation As A Multi-Platform NAAT Quality Control.” It reviews the performance of Microbix’s novel, innovative, and proprietary REDx™FLOQ® SARS-CoV-2 product – A tool for helping to ensure the accuracy of clinical laboratory “RT-PCR” testing...

Continue reading

NeuroMetrix Launches Quell® App for Apple Watch®, the First Smartwatch App for an Over-the-Counter Pain Relief Device

WOBURN, Mass., Sept. 22, 2020 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) today reported the launch of the Quell Watch App, now available for download from the Apple App store.Quell is a wearable, transcutaneous electrical nerve stimulation (TENS) device for knee, foot and leg pain that is available over-the-counter. It can be used during the day while active and at night while sleeping. Users can personalize and manage therapy discreetly via the mobile app for iPhone and Android smartphones. Quell is also a pain management solution with pain, sleep, activity and gait tracking. The Quell Health Cloud® provides customized feedback and powers one of the largest chronic pain outcomes databases. To learn more visit www.QuellRelief.com.Like Quell, a smartwatch is always on the body. This enables a high level of integration and...

Continue reading

Q BioMed, Inc. CEO Discusses Recently Announced International Market Authorizations and Expansion in to South and Central America and Asia for Q BioMed’s Strontium89, its FDA Approved Drug for the Non-Opioid Treatment of Metastatic Cancer in the Bone

AUSTIN, Texas, Sept. 22, 2020 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. (“SCV”) today announces the availability of a new interview with Q BioMed Inc. (“the Company”) (OTCQB: QBIO), a commercial stage biotech company, CEO Denis Corin, who discusses initial commercial uptake of Strontium89, its FDA approved drug for the non-opioid treatment of metastatic cancer in the bone. Corin added context and his insights into the other Company news regarding the GMP production contract has been initiated for MAN-19, a clinical grade therapeutic intended to treat complications caused by COVID-19. The Phase 1 clinical trial is slated to begin patient enrollment in February 2021.Denis Corin, CEO of Q BioMed, added, “We believe we have created a highly valuable pipeline of assets we hope to advance towards the patient populations we intend to...

Continue reading

RenalytixAI Receives California Commercial Laboratory Certification

NEW YORK, Sept. 22, 2020 (GLOBE NEWSWIRE) — Renalytix AI, Inc. (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announced today that it has received a California Clinical Laboratory License from the California Department of Health for its clinical laboratory in Salt Lake City, Utah. KidneyIntelX™ may now be used to report risk assessment of progressive decline in kidney function for patients in California with early stage diabetic kidney disease (DKD). With this certification, the Company is now licensed to provide KidneyIntelX testing services for patients in 49 states.According to the American Society of Nephrology, California has more than five million patients...

Continue reading

ALX Oncology to Collaborate with Merck on Phase 2 Immuno-Oncology Studies Evaluating ALX148, Targeting CD47, in Combination with KEYTRUDA® (pembrolizumab) in Patients with Head & Neck Cancer

BURLINGAME, Calif., Sept. 22, 2020 (GLOBE NEWSWIRE) — ALX Oncology (NASDAQ:ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced it has entered into a clinical trial collaboration with Merck, known as MSD outside the United States and Canada, to evaluate the combination of ALX148, an investigational next generation CD47 blocker, and KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, for the treatment of patients with Head & Neck Squamous Cell Carcinoma (HNSCC).Under the terms of the agreement, ALX Oncology will conduct a Phase 2 program comprising two separate Phase 2 studies. The first study will evaluate the efficacy of ALX148 in combination with KEYTRUDA for the first line treatment of patients with PD-L1 expressing metastatic or unresectable, recurrent...

Continue reading

AutoZone 4th Quarter Same Store Sales Increase 21.8%

4thQuarter EPS of $30.93Annual Sales of $12.6 BillionMEMPHIS, Tenn., Sept. 22, 2020 (GLOBE NEWSWIRE) — AutoZone, Inc. (NYSE: AZO) today reported net sales of $4.5 billion for its fourth quarter (16 weeks) ended August 29, 2020, an increase of 14.0% from the fourth quarter of fiscal 2019 (17 weeks). Excluding sales from the additional week included in last year’s quarter, adjusted sales were up 21.2%. Domestic same store sales, or sales for stores open at least one year, increased 21.8% for the quarter. Same store sales are computed on a 16-week basis.“As a result of the COVID-19 global pandemic, our primary focus has been and continues to be to protect the health and wellness of our customers and AutoZoners.  I’m very proud of the steps our team has taken in this regard and I’m very appreciative of the phenomenal efforts of our...

Continue reading

Comstock Mining Launches Geophysical Surveys of the Southern Comstock District Dayton Resource Area and Spring Valley Exploration Targets

VIRGINIA CITY, Nev., Sept. 22, 2020 (GLOBE NEWSWIRE) — Comstock Mining Inc. (the “Company”) (NYSE American: LODE) announced today that Geotech Ltd. (“Geotech”) of Aurora, Canada, began conducting the previously announced airborne geophysical surveys last weekend, including the Dayton resource area, adjacent to Silver City, NV and the contiguous Spring Valley exploration targets all the way to Hwy 50.  Geotech launched its proprietary Versatile Time-Domain Electromagnetic (“VTEM”) geophysical system on Saturday, September 19, 2020, once visibility improved as smoke from the California fires cleared, and plans to complete the survey, by the end of September. The Company expects preliminary scans becoming available by mid-October, and extensive three-dimensional interpreted results later in the fourth quarter.A photo accompanying this...

Continue reading

Brook Furniture Rental Optimizes Delivery Appointment Scheduling with Descartes Home Delivery Solution

WATERLOO, Ontario, Sept. 22, 2020 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Lake Forest, IL-based Brook Furniture Rental, a leading provider of rental furnishings for the office and home, selected Descartes’ delivery appointment scheduling and execution solution to improve its white glove delivery operations across 12 distribution centers in the U.S.“Our services include expert set-up at a time that works for our customers. Delivery appointment scheduling is a critical part of our service, whether we’re delivering a full home worth of furnishings to an individual or a complete office solution for a commercial client,” said Nathan Sanders, President & CEO at Brook Furniture Rental. “The Descartes solution is a powerful...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.